A detailed history of Reap Financial Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Reap Financial Group, LLC holds 1,405 shares of PFE stock, worth $36,670. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,405
Previous 776 81.06%
Holding current value
$36,670
Previous $22.5 Million 66.07%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 27, 2025

BUY
$24.8 - $30.19 $15,599 - $18,989
629 Added 81.06%
1,405 $37.3 Million
Q3 2024

Feb 27, 2025

SELL
$27.7 - $31.39 $110 - $125
-4 Reduced 0.51%
776 $22.5 Million
Q2 2024

Feb 27, 2025

SELL
$25.26 - $29.6 $1,667 - $1,953
-66 Reduced 7.8%
780 $21.8 Million
Q1 2024

Feb 27, 2025

SELL
$25.89 - $29.73 $103,534 - $118,890
-3,999 Reduced 82.54%
846 $23.5 Million
Q4 2023

Feb 27, 2025

BUY
$26.13 - $33.94 $126,599 - $164,439
4,845 New
4,845 $139 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $146B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Reap Financial Group, LLC Portfolio

Follow Reap Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Reap Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Reap Financial Group, LLC with notifications on news.